Pittsburgh Suboxone Doctors

Join Here To Have Your Medical Practice Featured in this space

Following payment completion, please send us the listing information you would like displayed here.

methadone8c

Pittsburgh has various treatment alternatives for people struggling with a chronic opioid addiction. Prescription opioids have become a substantial nationwide problem with more people now dependent on them than heroin. With the unprecedented rise in opioid addiction over the past decade, methadone and suboxone have become increasingly needed as treatment interventions to assist those coping with opiate withdrawal symptoms. Pittsburgh maintains a significant number of approved physicians able to write suboxone prescriptions. Suboxone is now more popular and is widely available across the U.S. based on its positive track record in alleviating opioid withdrawal. If you are a local physician aiming to treat Pittsburgh residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.



Pittsburgh Buprenorphine Suboxone Doctors
Allan William Clark, M.D. 850 Boyce Road
Suite 2
Pittsburgh, PA 15017
(724) 260-5179
Anthony J. Cancilla, M.D. 600 Washington Avenue
Suite 100
Pittsburgh, PA 15017
(412) 257-5900
April S. Clark, M.D. Summit Medical Services Pittsburgh
3121 Smallman Street
Pittsburgh, PA 15201
(412) 281-1521
Ronald Rager, M.D. 575 Lincoln Avenue
Pittsburgh, PA 15202
(412) 734-1100
Parviz Jian, M.D. 575 Lincoln Avenue
Suite LL
Pittsburgh, PA 15202
(412) 766-6888
Joseph Fine, M.D. 575 Lincoln Avenue
Pittsburgh, PA 15202
(412) 734-1100
David Louis Blinn, M.D. 575 Lincoln Avenue
Pittsburgh, PA 15202
(412) 761-5535
Dilwara Begum, M.D. 575 Lincoln Avenue
Pittsburgh, PA 15202
(412) 734-1100
Frank R. Santamaria, M.D. 1517 Forbes Avenue
Pittsburgh, PA 15202
(412) 232-3555
Paul D. Bianculli, M.D. 575 Lincoln Avenue
Ll1
Pittsburgh, PA 15202
(412) 734-1100
Nadeem Ahmed, M.D. 330 South 9th Street
Pittsburgh, PA 15203
(412) 488-4040
Daniel David Janiak, D.O. Crafton Medical Center
1 Walsh Road
Pittsburgh, PA 15205
(412) 921-1104
Michael Xuehui Su, M.D. Oxford Building 3501 Forbes Ave, Rm 926
Western Psychiatric Institute and Clinic
Pittsburgh, PA 15206
(412) 246-5948
Frances M. Southwick, D.O. 117 North Negley Avenue
Pittsburgh, PA 15206
(412) 404-4000
John A. Gurklis, Jr, M.D. VA Pittsburgh Health Care System
7180 Highland Drive
Pittsburgh, PA 15206
(412) 365-5160
Daniel Paul Lapp, M.D. 117 North Negley Avenue
Pittsburgh, PA 15206
(412) 404-4000
Frank Alfred Kunkel, M.D. 748 North Negley Avenue
Suite X
Pittsburgh, PA 15206
(724) 591-5236
Ben Peter Jagiello, M.D. 748 North Negley Avenue
Pittsburgh, PA 15206
(724) 591-5236
Robert A. Lowenstein, M.D. 211 North Whitfield Street
Suite 475
Pittsburgh, PA 15206
(412) 661-5437
Arnold J. Snitzer, M.D. 748 North Negley Avenue
Pittsburgh, PA 15206
(724) 591-5236
Abimbola Yabo Talabi, M.D. 748 North Negley Avenue
Pittsburgh, PA 15206
(724) 591-5236
Felicia Young, M.D. 7227 Hamilton Avenue
Pittsburgh, PA 15208
(412) 244-4700
Carol Zisowitz, M.D. Wpic
6714 Kelly St.
Pittsburgh, PA 15208
(412) 363-7383
George McCollum, M.D. 514 Beltzhoover Avenue
Pittsburgh, PA 15210
(412) 431-3080
Norman J. Frey III, D.O. 20 Bailey Avenue
Pittsburgh, PA 15211
(412) 381-4200
Nosratollah Danaie, M.D. 20 Bailey Avenue
Pittsburgh, PA 15211
(412) 381-1600
Gulam Ali Akther Noorani, M.D. Allegheny General Hospital
320 East North Avenue
Pittsburgh, PA 15212
(201) 394-7271
Harvey D. Shipkovitz, M.D. 1312 Federal Street
Pittsburgh, PA 15212
(412) 321-0255
Muhammad Hamza Habib, M.D. UPMC Montefiore 933 West
200 Lothrop Street
Pittsburgh, PA 15213
(412) 692-4839
Julie A. Kmiec, D.O. 3811 O'Hara Street
Pittsburgh, PA 15213
(412) 363-7383
Antoine B. Douaihy, M.D. 3811 O'Hara Street
Suite 1059
Pittsburgh, PA 15213
(412) 586-9537
Gerald D. Klug, M.D. 3528 Boulevard of the Allies
Pittsburgh, PA 15213
(412) 681-1406
Venkat Laxman Reddy, M.D. Priority Health Care
3528 Boulevard of the Allies
Pittsburgh, PA 15213
(412) 681-1406
Phyllis Montellese, M.D. 128 North Craig Street
Suite 216
Pittsburgh, PA 15213
(412) 681-3200
Jordan Friedman Karp, M.D. WPIC; Bellefield Tower location
100 N Bellefield Ave. Lower Level Pharm.
Pittsburgh, PA 15213
(412) 246-6048
Garrett Matthew Sparks, M.D. 3811 O'Hara Street
Pittsburgh, PA 15213
(412) 586-9331
Jessica Cipoletti Derreberry, M.D. Oxford Building
3501 Forbes Avenue, Room 926
Pittsburgh, PA 15213
(412) 246-5948
Duane Gerald Spiker, M.D. WPIC – BT 806
3811 O'Hara Street
Pittsburgh, PA 15213
(412) 246-5400
Phu Gia Phan, M.D. WPIC, UPMC
3811 O'Hair Street
Pittsburgh, PA 15213
(412) 246-5710
Curtis Vincent Mayernik, M.D. Western Psychiatric Institute of UPMC
3811 O'Hara Street
Pittsburgh, PA 15213
(412) 246-5819
Angelo Constantino, M.D. 200 Delafield Road, Suite 4005
200 Medical Arts Building
Pittsburgh, PA 15215
(412) 784-2323
Fereydoon Daniel Radfar, M.D. 2987 West Liberty Avenue
Pittsburgh, PA 15216
(412) 344-4010
Manuel D. Reich, D.O. 6640 Forest Glen Road
Pittsburgh, PA 15217
(724) 260-5179
Ben Peter Jagiello, M.D. 1900 Murray Avenue
Pittsburgh, PA 15217
(724) 591-5236
Frank Alfred Kunkel, M.D. 1900 Murray Avenue
Suite 301
Pittsburgh, PA 15217
(724) 591-5236
Robert A. Woolhandler, M.D. 5562 Wilkins Avenue
Pittsburgh, PA 15217
(412) 422-0500
Leonard Merkow, M.D. 3301 Beechwood Boulevard
Pittsburgh, PA 15217
(412) 521-0477
Paul S. Caplan, M.D. 1900 Murray Avenue
Suite 301
Pittsburgh, PA 15217
(888) 309-4738




Helping Skeptics Understand Methadone

When it comes to addiction, reactions and opinions are often intense. Addiction is a devastating illness that can rapidly derail a person’s life, and seriously impact the lives of those around them.

Sadly, addiction leads people to behave in ways that make no sense to their family, friends, and co-workers. Therein lies an important part of the problem. Family feel confused, angry, and fearful as their loved one tumbles down the hill of active addiction.

When it comes to something as perplexing as drug addiction, grasping for answers is an understandable reflex for family and friends. What family often don’t comprehend is the power of physical dependency to opioids and the severe sickness that results from opioid withdrawal.

Family and others incorrectly assume that mere “choice” is all that’s needed to overcome the addiction. When the addict fails to remain drug free, harsh judgment by others usually follows.

Halting withdrawal sickness is a paramount step for an opioid addicted person. This cannot be overstated. As long as a person is suffering from severe opioid withdrawal, their ability to think and “choose” logically is greatly impaired.

Statistically, individuals who utilize medication-assisted treatment (like methadone) are far more likely to avoid incarceration, a continued downward spiral, or death by overdose. Medication assistance successfully removes debilitating withdrawal sickness so that the addicted person can experience greater clarity of thought and the ability to make more sound decisions that lead to improved quality of life.

If you are a skeptic about methadone or suboxone, you may think “they’re just trading one drug for another”. This is not true. People, once therapeutically stabilized on methadone or suboxone, do not get high from the medication. Health generally improves, and the person is able to function much better on the job and at home. This brings hope. It offers a new opportunity for further recovery.

When you care about a person’s survival, one more chance to help them can be quite valuable. Don’t let judgment or excessive skepticism get in the way. Medication-assistance in opioid recovery is effective for many people, and it has been the life saving next step that some never got the chance to take.

Posted in Methadone, Methadone Benefits, Methadone Clinics, Recovery, Suboxone | Tagged | Comments Off on Helping Skeptics Understand Methadone

Methadone Treatment in Oregon

Like most states, Oregon is in need of quality treatment options for opioid-addicted individuals who are ready for recovery.

This article, in the Hillsboro News-Times, features the recent approval by Washington County commissioners to add a new methadone clinic in Hillsboro, Oregon.

Acadia Healthcare is aiming to establish the new methadone clinic in Hillsboro in order to better serve the local community. Acadia already operate a mobile unit in the general area as well as a comprehensive treatment center (CTC) in nearby Tigard located about 20 miles away.

The commissioners voted 5-0 to approve the proposed site which will be on the local bus route thereby providing improved access. The article mentions that Oregon presently has 17 operational methadone clinics serving the state, where fentanyl, opiates, and other substances are causing a grave overdose crisis.

Having local opioid treatment available is a critically important step in saving lives and providing hope to patients and families. Methadone has been proven to decrease opioid use, reduce relapse risks & overdose deaths, as well as increase employment and overall health. Clinics offering medication-assisted treatment (MAT), like methadone and buprenorphine, are forging a new path to safety for those people once stuck in active addiction.

Posted in Acadia Healthcare, Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Oregon Methadone Clinics, Suboxone | Tagged , , | Comments Off on Methadone Treatment in Oregon

Remote Observation of Methadone Dosing

There’s a new spin being proposed on the dispensing of methadone to Opioid Use Disorder (OUD) patients. A federally-funded project is underway between Scene Health and The University of Washington in which patients video themselves taking their daily methadone dose, and then submit that video to the treatment provider.

The project is evaluating this new modified approach that falls somewhere between in-person daily dosing and unsupervised take home dosing.

This new approach is currently being referred to as Video DOT (video direct observation therapy) and has been successfully implemented with other health issues including hepatitis C, asthma, and diabetes.

While this experiment seems appealing at first glance, it does raise legitimate questions about the ability to insure proper safety protocols with the provision of methadone medication to new patients. The project may possibly demonstrate the usefulness of Video DOT methadone dosing. But assuming this new approach one day becomes common practice, it will be important that physicians or clinics have in place a procedure for quickly reclaiming methadone doses that are not ingested on schedule.

Imagine a new patient receives 7 take home doses of methadone, but then only sends in the required video of their medication use on day one. At what point does the prescribing clinic intervene, and how will the unaccounted for doses be retrieved?

Approved Opioid Treatment Programs currently have “callback” procedures in which stable patients are randomly selected to return to their home clinic with their unused take home doses. This allows the clinic medical staff to perform a medication count, and it acts as a safeguard to insure patients are taking their medication as prescribed.

Patients who have earned take home privileges through months of treatment progress are less inclined to divert or misuse methadone than someone who just started treatment. New patients must be inducted gradually on a stabilizing dose of methadone. And time is typically needed to help these patients adjust to methadone while eliminating use of all other illicit substances. This is where the benefit of a structured treatment program is most relevant. OTP’s provide extremely valuable life management skills training in conjunction with medication therapy.

It remains to be seen if “easy access” to methadone is truly an advancement in care, or a step backwards in accountability & safety for patients and the public.

Posted in Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Programs, Suboxone, Suboxone Clinics | Tagged | Comments Off on Remote Observation of Methadone Dosing

Expanding Access to Methadone

Historically, access to methadone for the treatment of opioid addiction has been through enrollment in a local clinic licensed to dispense methadone. As a result of Covid restrictions, some of these clinic regulations were relaxed. For example, many patients across the U.S. were allowed to begin receiving take home doses of methadone as a result of Covid lockdowns and decreased clinic access.

Critics have begun to express the belief that clinic restrictions are cumbersome and that methadone should be made available for pick-up at local pharmacies. On the other hand, the concern remains that methadone can be misdirected or mishandled thus reinforcing the need for close supervision, particularly in the early phases of opioid treatment. Decades of research has shown that taken under proper supervision, methadone’s safety profile is excellent.

In this recent era of contaminated street opiates and overdose concerns, it is clear that methadone is a phenomenally effective medication for promoting health, well-being, and physical safety.

Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, recently shared that deregulation of methadone would likely increase the diversion of methadone and methadone-related overdose deaths.

Following a period of stability, most U.S. clinics do allow patients to begin dosing at home with methadone. This system of care is working well throughout the country where methadone is readily available. However, many U.S. citizens are still lengthy distances from methadone-approved clinics. So, the challenge continues to link those with opioid addiction to effective resources in their local community. Legislators are presently examining a range of options as the opioid epidemic marches on.

Posted in Acadia Healthcare, Addiction Treatment, Brightview, Methadone, Methadone Clinics, Opioid Treatment, Suboxone | Tagged | Comments Off on Expanding Access to Methadone